Two out of three Americans with invasive cancer—the kind that has spread to nearby healthy tissue—are living five years or more after diagnosis, according to a new report from the U.S. Centers for Disease Control and Prevention (CDC).

Data has shown that early detection and innovation in cancer treatment have increased the number of cancer survivors over the last several years, and the new report, published in the CDC’s Morbidity and Mortality Weekly Report, shows that even patients with invasive cancer have encouraging survival rates.

To reach these numbers, CDC researchers looked at the number of cancer cases reported to U.S. cancer registries in 2011, the year of the most recently available data. That year saw 1,532,066 invasive cancer cases, or 451 cases per 100,000 people.

The CDC reports that the most common cancer sites were prostate, breast, lung, and colon and rectum. The five-year survival rates for those cancers came out to 97% for prostate cancer, 88% for breast cancer, 63% for colorectal cancer and 18% for lung cancer. While the rates were relatively even among men and women, racial disparities existed; 65% of white people had a five-year relative survival rate, and 60% of black people had the same.

In the report, the researchers say they hope public health experts use the data to determine what groups of people have higher rates of cancer and lower rates of survival. These groups may benefit most from cancer control efforts. “Using these data to effectively develop comprehensive cancer control programs, including supporting the needs of cancer survivors, can help reduce cancer incidence and improve survival,” the authors write.

Get our Health Newsletter. Sign up to receive the latest health and science news, plus answers to wellness questions and expert tips. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Contact us at letters@time.com.